Maryland is among the top tier of states in the size and
concentration of its bioscience and biomedical research complex
–(BUSINESS WIRE)–Senator Van Hollen will join the leaders of Maryland biotechnology
company GlycoMimetics for a tour of the company’s facilities before
participating in a roundtable discussion on the economic and societal
value of biotech innovation.
Senator Van Hollen will learn more about prospects for, and impediments
to, the continued growth of this high-wage industry in Maryland. The
Senator also will discuss the potentially significant effects of the
federal health care policy and budget debates.
|Tour and Roundtable Discussion at GlycoMimetics|
Maryland Senator Chris Van Hollen
Jim Greenwood, President & CEO, BIO
Rachel King, CEO, GlycoMimetics, Inc.
Other senior leadership from GlycoMimetics
|Friday, December 8, 2017 from 9:45 am – 11:00 am|
|9708 Medical Center Drive|
|Rockville, MD 20850|
Media requested to RSVP to George Goodno, mailto:email@example.com
BIO is the world’s largest trade association representing biotechnology
companies, academic institutions, state biotechnology centers and
related organizations across the United States and in more than 30 other
nations. BIO members are involved in the research and development of
innovative healthcare, agricultural, industrial and environmental
biotechnology products. BIO also produces the BIO
International Convention, the world’s largest gathering of the
biotechnology industry, along with industry-leading investor and
partnering meetings held around the world. BIOtechNOW
is BIO’s blog chronicling “innovations transforming our world” and the
BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe
to the BIO Newsletter.
Biotechnology Innovation Organization